about
Epigenomics of leukemia: from mechanisms to therapeutic applicationsDifferential expression of PDZ domain-containing proteins in human diseases - challenging topics and novel issuesEpigenetic alteration by DNA-demethylating treatment restores apoptotic response to glucocorticoids in dexamethasone-resistant human malignant lymphoid cellsGut Microbiota Species Can Provoke both Inflammatory and Tolerogenic Immune Responses in Human Dendritic Cells Mediated by Retinoic Acid Receptor Alpha Ligation.Frequent and simultaneous epigenetic inactivation of TP53 pathway genes in acute lymphoblastic leukemiaThe future of primary intraocular lymphoma (retinal lymphoma).Leukaemogenesis: more than mutant genesSafety and clinical activity of 5-aza-2'-deoxycytidine (decitabine) with or without Hyper-CVAD in relapsed/refractory acute lymphocytic leukaemia.Epigenetic inactivation of Notch-Hes pathway in human B-cell acute lymphoblastic leukemia.PCDH10 promoter hypermethylation is frequent in most histologic subtypes of mature lymphoid malignancies and occurs early in lymphomagenesis.Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium.Emerging pharmacotherapies for adult patients with acute lymphoblastic leukemia.RBP2 Promotes Adult Acute Lymphoblastic Leukemia by Upregulating BCL2.Adult acute lymphoblastic leukemia: concepts and strategies.Relationship between ABO blood group and Acute Lymphoblastic Leukemia.Targeting epigenetics through histone deacetylase inhibitors in acute lymphoblastic leukemia.Intrauterine growth and childhood leukemia and lymphoma risk.Epigenetic modifications in pediatric acute lymphoblastic leukemia.Unlocking the potential of retinoic acid in anticancer therapy.Epigenetic roots of immunologic disease and new methods for examining chromatin regulatory pathways.Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia.Epigenetic drug combination overcomes osteoblast-induced chemoprotection in pediatric acute lymphoid leukemia.Significance of Inactivated Genes in Leukemia: Pathogenesis and PrognosisSilencing of TESTIN by dense biallelic promoter methylation is the most common molecular event in childhood acute lymphoblastic leukaemiaPromoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance.Aberrant EPHB4 gene methylation and childhood acute lymphoblastic leukemia.FHIT promoter DNA methylation and expression analysis in childhood acute lymphoblastic leukemia.Newly diagnosed acute lymphoblastic leukemia in China (I): abnormal genetic patterns in 1346 childhood and adult cases and their comparison with the reports from Western countries.Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family.
P2860
Q26823403-EB938E5E-1AD9-4928-9229-254711CD69F8Q27015135-041332A2-6AA0-44CA-804A-7D8B4AA5CA03Q33559964-3AB69324-50DC-472A-8F15-1C14853982BCQ33571508-C0DC0B45-84CE-456F-81D1-A622E4C68066Q33840913-D16C1157-9ABE-49A0-8202-6DD5DB7EA334Q33950795-09831F6A-F214-4913-95DD-3F128F011FA6Q34275371-42E45E05-CE71-4AF1-9E27-7EB2BF5B5EBAQ34345218-7AAB8A7E-0C0D-4AE5-96BE-84D61F003501Q34700660-F9036CC8-F3C1-475E-AA5E-D556D40E27F0Q34912713-69C59AD0-45D0-455F-9E6D-BBFA9DC2DE1DQ35599811-C17CD80E-09A3-499D-9017-DB69EF94348CQ35740894-6A7315D0-8C6E-4A1A-AC1C-31935EA6329DQ35967910-F40FC1F8-50D4-4170-BDB0-D08462583545Q37681450-ACC87CD4-9019-4567-A438-B878CB08128FQ37692774-8CD68FB0-D955-429B-9117-6A660ACAC368Q37901485-A1040E40-45E1-444D-9B7D-831FF54026DBQ38059254-EE244CD3-446B-483E-B48F-F75EB2879685Q38214773-AEE1D050-66C1-4856-B41D-43BB79914B50Q38269931-6DEBF69A-AC03-4DD1-880D-B589144EC507Q38297582-37D6C52D-23A6-4DC0-AF7F-26B170A75C2CQ38327984-2E94FB33-7B66-4182-B83A-FCCCF0461557Q38973962-B9DC4730-359A-40FC-9F16-59F0F246DD33Q39350173-E6F4E111-603F-4D05-90D8-20148705A87DQ39396703-4A052D0A-94ED-48F9-A654-0F6F505ACFF0Q39465369-C94AB1D6-4899-48B4-B3A0-2F7232D0CD4BQ45355262-38094F5E-100A-4FC7-A86E-D814B6A6699DQ46235892-24CC4092-BBBE-4F4A-B6FD-2EC940B386D2Q47221339-0C552344-C56D-4765-9D86-329CFBB04952Q54570256-4603A061-3D1F-4BD5-B76E-AA7E39A8C8B9
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epigenetics of acute lymphocytic leukemia.
@en
Epigenetics of acute lymphocytic leukemia.
@nl
type
label
Epigenetics of acute lymphocytic leukemia.
@en
Epigenetics of acute lymphocytic leukemia.
@nl
prefLabel
Epigenetics of acute lymphocytic leukemia.
@en
Epigenetics of acute lymphocytic leukemia.
@nl
P2093
P2860
P50
P1476
Epigenetics of acute lymphocytic leukemia.
@en
P2093
Deborah Thomas
Shao-Qing Kuang
P2860
P356
10.1053/J.SEMINHEMATOL.2008.09.008
P577
2009-01-01T00:00:00Z